secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2022-06-14T23:59:59+00:00
Accession:  0000950170-22-011589
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks shareholders elect eight directors and ratify EY at 2022 annual meeting
--------------------------------------------------------------------------------

- Quorum of 81.47% of combined Class A and Class B voting power; 859.9M Class A and 351.5M Class B shares present.
- All eight director nominees elected: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar, Harry E. Sloan.
- Ratification of Ernst & Young as independent auditor for FY2022 approved with 4,365,263,156 votes for and 5,152,427 against.
- Annual meeting held June 10, 2022; no other proposals or director nominations brought before shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000095017022011589/0000950170-22-011589-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000095017022011589/dna-20220610.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011589

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer